Literature DB >> 18322661

Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8.

M Vidaurreta1, M L Maestro, M T Sanz-Casla, S Rafael, S Veganzones, V de la Orden, J Cerdán, M Arroyo, A Torres.   

Abstract

BACKGROUND AND AIMS: Gene p53 alteration is a genetic event described in the progression from adenoma to colorectal carcinoma. Most of the p53 mutations occur in exons 5 to 8 in highly preserved regions and in the three main structural domains of the p53 protein. It is possible that mutations affecting different structural regions may present different effects on the p53 protein function and, due to this, they may have different prognostic meaning.
MATERIALS AND METHODS: The study population consisted of 353 patients diagnosed with sporadic colorectal cancer. Mutations in 5-8 exons of p53 gene were detected by means of single strand conformation polymorphism (SSCP). All samples that showed different migration bands in SSCP were confirmed by sequencing.
RESULTS: A total of 69 patients (19.7%) showed alterations of the gene p53. It was observed that mutation in codon 175 in exon 5 was related to tumors located in the colon (p = 0.01) and the mutation in the codon 288 in exon 8 was related to rectal tumors (p = 0.02). In the study of overall survival, mutation in codon 175 of exon 5 conferred a better prognosis and alterations of exon 8 were related to a worse prognosis in different population subgroups: in men, in patients younger than 71 years old, in the tumors located in the proximal colon, the ones moderately differentiated, and those that are mucinous.
CONCLUSION: According to this study, mutations in different exons of p53 are related to different phenotypes in colorectal cancer. These phenotypes could mean differences in the clinical evolution of the patients.

Entities:  

Mesh:

Year:  2008        PMID: 18322661     DOI: 10.1007/s00384-008-0454-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

Review 1.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

2.  p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.

Authors:  H Elsaleh; B Powell; P Soontrapornchai; D Joseph; F Goria; N Spry; B Iacopetta
Journal:  Oncology       Date:  2000       Impact factor: 2.935

Review 3.  The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

Authors:  Antonio Russo; Viviana Bazan; Barry Iacopetta; David Kerr; Thierry Soussi; Nicola Gebbia
Journal:  J Clin Oncol       Date:  2005-09-19       Impact factor: 44.544

4.  p53 point mutation and survival in colorectal cancer patients: effect of disease dissemination and tumour location.

Authors:  H S Goh; J Elnatan; C H Low; D R Smith
Journal:  Int J Oncol       Date:  1999-09       Impact factor: 5.650

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

Authors:  K Servomaa; A Kiuru; V M Kosma; P Hirvikoski; T Rytömaa
Journal:  Mol Pathol       Date:  2000-02

Review 7.  The UMD-p53 database: new mutations and analysis tools.

Authors:  Christophe Béroud; Thierry Soussi
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

8.  The dominant-negative effect of p53 mutants and p21 induction in tetraploid G1 arrest depends on the type of p53 mutation and the nature of the stimulus.

Authors:  Walid Dridi; Raouf Fetni; Josée Lavoie; Marie-France Poupon; Régen Drouin
Journal:  Cancer Genet Cytogenet       Date:  2003-05

9.  Colon cancer-associated DNA mutations: marker selection for the detection of proximal colon cancer.

Authors:  Barry M Berger; Lauren Robison; Jonathan Glickman
Journal:  Diagn Mol Pathol       Date:  2003-12

10.  p53 alterations are associated with improved prognosis in distal colonic carcinomas.

Authors:  R Soong; F Grieu; P Robbins; B Dix; D Chen; R Parsons; A House; B Iacopetta
Journal:  Clin Cancer Res       Date:  1997-08       Impact factor: 12.531

View more
  7 in total

1.  Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.

Authors:  Chaar Ines; Ounissi Donia; Boughriba Rahma; Azza Ben Ammar; Amara Sameh; Taher Khalfallah; Ben Hmida Abdelmajid; Mzabi Sabeh; Bouraoui Saadia
Journal:  Tumour Biol       Date:  2014-04-25

2.  Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma.

Authors:  Tereza Hálková; Renata Ptáčková; Anastasiya Semyakina; Štěpán Suchánek; Eva Traboulsi; Ondřej Ngo; Kateřina Hejcmanová; Ondřej Májek; Jan Bureš; Miroslav Zavoral; Marek Minárik; Lucie Benešová
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

Review 3.  "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Shaymaa M M Yahya; Ashraf El Sherbini; Mervat S Mohamed; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2013-04-04

4.  High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.

Authors:  Lei Zheng; Ganfeng Xie; Guangjie Duan; Xiaochu Yan; Qianwei Li
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

5.  Distinct pattern of mutations of conserved regions of TP53 in colorectal cancer patients in the Kashmir population: an emerging high-risk area.

Authors:  S Rehman; As Sameer; L Zahoor; S Abdullah; Za Shah; D Afroze; I Hussain; Sm Shaffi; N Syeed; Ma Rizvi; Ma Siddiqi
Journal:  Ecancermedicalscience       Date:  2009-01-09

6.  Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.

Authors:  A Syed Sameer; Shakeel ul Rehman; Arshad A Pandith; Nidda Syeed; Zaffar A Shah; Nissar A Chowdhri; Khursheed A Wani; Mushtaq A Siddiqi
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

7.  TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Wen-Jen Wu; Li-Ching Chang; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.